Search

everythinglearnresearchcommunity

for

Search:↓

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Nanotube-based hair treatments could improve hair health and growth, and offer long-lasting effects.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Drug misuse can cause serious eye infections and other severe side effects.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Centipeda minima extract helps hair grow by activating important growth signals and could be a promising hair loss treatment.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Histone H4, released by cells exposed to colchicine, can cause hair loss by inhibiting cell growth and enzyme activity.

Scientists can now grow hair-like structures in a lab using special 3D culture systems, which could potentially help people with hair loss or severe burns.

Surgical hair restoration was the best permanent solution for baldness in 2005.

Some medications can cause reversible hair loss by affecting hair growth cycles.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Hair growth dysfunction involves various conditions with limited treatment options.

Hair follicle systems are being engineered to better mimic natural hair follicles for studying hair disorders and testing treatments.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Microneedling therapy leads to better treatment adherence than drug therapy for hair loss.

SLE in Iraqi patients often involves hair loss and photosensitivity, with common treatments being corticosteroids and immunosuppressants.

Oral minoxidil rarely causes pericardial effusion, especially at low doses.

New non-surgical treatments for hair loss show promising results with fewer side effects.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Good medication adherence improves quality of life in subclinical thyroid disorder patients.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Human induced pluripotent stem cells can be used to create cells that help grow hair.